Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLL.L Regulatory News (CLL)

  • There is currently no data for CLL

Acquisition

23 Oct 2007 07:01

Cello Group plc23 October 2007 23 October 2007 Cello Group plc Acquisition of 2CV extends research capabilities Cello Group plc ("Cello", AIM: CLL), the market research and consulting grouphas acquired 2CV Limited ("2CV"), a specialist consumer market researchconsultancy. Initial consideration is approximately £5.4 million with furtherperformance related consideration of up to a maximum of £5.5 million. 2CV, which was founded in 1996 by Vincent Nolan, provides market research andconsultancy services to a number of major global brands. It also advises clientson product development, creative marketing communications and strategic mediaplanning. The initial consideration consists of approximately £5.4 million of which £3.5million is payable in cash and loan notes, with the balance satisfied by theissue of 1,330,731 new ordinary shares. In addition, there are furtherperformance related payments over the period to 31 December 2010. These furtherpayments are in a mixture of loan notes and new ordinary shares at Cello'sdiscretion, with a minimum overall loan note consideration of approximately 50%of the further consideration. For the year to 31 May 2007, 2CV had an audited turnover of £5.7 million, grossprofit of £4.0 million and profits before tax of £0.7 million. Net assets as at31 May 2007 were £0.7 million including cash of £0.5 million. Application has been made to the London Stock Exchange for the new shares to beadmitted to AIM and it is expected that admission will take place by 26 October2007. Kevin Steeds, Cello Chairman, said: "2CV has an excellent reputation within the marketing industry as athought-leading and innovative consumer insight agency. The 2CV acquisition isconsistent with our strategy of building a substantial international research &consulting group." Enquiries: Cello GroupKevin Steeds, Executive Chairman 020 7812 8460 College HillAdrian Duffield/Rozi Morris 020 7457 2020 Evolution SecuritiesBobbie Hilliam 020 7071 4347 Notes to Editors (www.cellogroup.co.uk) Cello is a market research and consulting group that listed on AIM in November2004. The Group's strategy is to create value for shareholders by building aportfolio of research and consulting businesses capable of advising blue chipclients globally. Cello has annualised turnover in excess of £100 million, operating income ofover £55 million and employs approx 650 professional staff. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
11th Jan 20064:35 pmRNSNotifiable Interest
11th Jan 20067:00 amRNSPre Close Trading Statement
3rd Jan 20063:44 pmRNSHolding(s) in Company
19th Dec 20057:17 amRNSAcquisition
16th Dec 20051:57 pmRNSAdditional Listing
25th Nov 200512:53 pmRNSAcquisition
20th Oct 20058:00 amRNSInvestor Presentation
14th Oct 20058:00 amRNSChange of Adviser
3rd Oct 20057:00 amRNSOMP Services
27th Sep 20057:02 amRNSInterim Results
2nd Sep 200511:41 amRNSNotice of Results
1st Aug 20057:00 amRNSAcquisition
18th Jul 20057:00 amRNSAcquisition
14th Jul 20059:14 amRNSHolding(s) in Company
11th Jul 20057:00 amRNSPre Close Trading Statement
4th Jul 20055:44 pmRNSHolding(s) in Company
1st Jul 20057:00 amRNSAcquisition
7th Jun 20052:46 pmRNSDirector Share Option Award
6th Jun 20054:43 pmRNSAcquisition Agreement
23rd May 200512:30 pmRNSAGM Statement
4th May 20058:41 amRNSBoard Appointment
25th Apr 20057:00 amRNSBoard Appointment
14th Mar 20057:01 amRNSFinal Results
10th Mar 20054:18 pmRNSHolding(s) in Company
1st Feb 200512:00 pmRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.